Bionic eye gives hope to the blind
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.
Feb 5, 2013
0
0
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.
Feb 5, 2013
0
0
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).
Jul 19, 2018
0
1795
Jessica Starr, a meteorologist at a local station in Detroit, should have been happier on Nov. 13.
Dec 16, 2018
0
86
University of Virginia Health System researchers have developed a potential therapeutic treatment for dry eye, with human testing to start in March. The drug differs from other treatments of dry eye in that it aims to treat ...
Jan 6, 2017
0
28
Markers that indicate the presence of Parkinson's disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team.
Aug 21, 2023
0
338
Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid. They are also the ...
Oct 12, 2019
0
401
(Medical Xpress) -- Researchers at UCLA's Jules Stein Eye Institute and colleagues who successfully transplanted specialized retinal cells derived from human embryonic stem cells into the eyes of two legally blind patients ...
Jan 24, 2012
0
0
Scientists have used gene therapy to regenerate damaged nerve fibres in the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the leading causes of blindness worldwide.
Nov 5, 2020
1
550
Scientists at the University of Birmingham have developed a novel eye drop that rapidly reduces sight-threatening scarring to the surface of the eye.
Dec 21, 2018
0
235
(Medical Xpress)—Biogen Idec Inc has released preliminary results of a phase II clinical trial (called RENEW) meant to test the effectiveness of using an anti-LINGO-1 drug called BIIB033, to treat eye damage that occurs ...